|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.140 USD | +2.22% |
|
-6.33% | +52.77% |
| Jun. 04 | NRX Pharmaceuticals Closes $22.3 Million Stock Offering | MT |
| Jun. 03 | NRX Pharmaceuticals Prices Public Offering of 5.7 Million Shares | MT |
Chart calendar NRx Pharmaceuticals, Inc.
Upcoming events on NRx Pharmaceuticals, Inc.
No events available
Past events on NRx Pharmaceuticals, Inc.
| 2026-05-18 | Earnings presentation | 08:00 am |
| 2026-05-18 | Earnings release - Q1 2026 | |
| 2026-03-24 | Earnings release - Annual 2025 | |
| 2026-03-24 | Earnings presentation | 08:00 am |
| 2026-03-23 | Présentation aux Actionnaires / Analystes | 10:00 am |
| 2026-03-23 | Annual General Meeting | 10:00 am |
| 2025-12-02 | Information meeting | 09:00 am |
| 2025-11-17 | Earnings presentation | 08:30 am |
| 2025-11-17 | Earnings release - Q3 2025 | |
| 2025-08-20 | Earnings presentation | 08:00 am |
| 2025-08-19 | Earnings release - Q2 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 1,23 11,8 -89.63% | 13,0 | 204 | 992 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -16,2 -13,7 -17.91% | -15,0 | 43,3 | 165 |
|
EBIT Million USD | Released Forecast Spread | -27,8 -29,6 5.8% | -18,5 -21,6 14.44% | -16,2 -11,6 -39.74% | -16,9 | 12,0 | 163 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -25,1 -21,7 -15.66% | -28,6 -25,5 -12.33% | -12,0 | 29,6 | 163 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -25,1 -21,4 -17.68% | -28,6 -25,5 -12.33% | -13,6 | 12,1 | 163 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | -2,36 -1,91 -23.78% | -1,34 -1,16 -15.85% | -0,32 | 0,23 | 2,49 |
| Announcement Date | 29/03/24 | 14/03/25 | 23/03/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,24 6,08 -96.02% | 0,98 7,53 -86.94% | 1,07 19,4 -94.5% | 1,43 | 1,73 | 8,73 | 28,1 | 42,5 | 58,6 | 74,8 |
|
EBITDA Million USD | Released Forecast Spread | -4,00 -1,60 -149.75% | -4,58 -2,10 -118.19% | -4,68 1,10 -525.36% | -2,60 | -3,40 | -4,30 | ||||||||
|
EBIT Million USD | Released Forecast Spread | -3,02 -6,65 54.56% | -2,43 -5,57 56.31% | -3,85 -4,04 4.85% | -3,73 -4,14 9.81% | -4,02 -0,60 -576.3% | -4,62 -0,01 -49889.19% | -4,74 8,48 -155.91% | -3,92 | -3,69 | -3,32 | -2,18 | -1,87 | -0,31 | 1,25 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1,62 -6,80 76.13% | -9,08 -5,67 -60.2% | -5,51 -4,35 -26.86% | -17,6 -4,73 -272.08% | -5,89 -0,68 -761.74% | 0,36 -0,14 349.13% | -1,43 12,6 -111.36% | -2,70 | -3,50 | -4,40 | 0,10 | 1,60 | 5,60 | 9,60 |
|
Net income Million USD | Released Forecast Spread | -1,62 -6,80 76.13% | -9,08 -5,27 -72.37% | -5,51 -4,19 -31.56% | -17,6 -4,28 -310.93% | -5,89 -0,68 -761.74% | 0,36 -0,14 349.13% | -1,43 6,14 -123.27% | -3,85 | -3,62 | -3,29 | -2,13 | -1,82 | -0,26 | 1,30 |
|
EPS USD | Released Forecast Spread | -0,15 -0,56 72.97% | -0,77 -0,37 -110% | -0,34 -0,27 -28.3% | -0,98 -0,26 -276.92% | -0,27 -0,03 -730.77% | 0,20 0,00 8100% | -0,04 0,21 -119.23% | -0,09 | -0,09 | -0,09 | -0,03 | 0,01 | 0,08 | 0,17 |
| Announcement Date | 14/11/24 | 14/03/25 | 15/05/25 | 18/08/25 | 14/11/25 | 23/03/26 | 15/05/26 | - | - | - | - | - | - | - |
| 2026-06-08 |  | Annual General Meeting | |
| 2026-06-08 | | Annual General Meeting | |
| 2026-06-08 | | Annual General Meeting | |
| 2026-06-08 | | Extraordinary General Meeting | |
| 2026-06-08 | | Annual General Meeting | |
| 2026-06-08 | | Annual General Meeting | |
| 2026-06-08 | | Annual General Meeting | |
| 2026-06-08 | | Annual General Meeting | |
| 2026-06-09 | | Annual General Meeting | |
| 2026-06-09 | | Présentation aux Actionnaires / Analystes | 11:00 am |
Past sector events for NRx Pharmaceuticals, Inc.
| 2026-06-04 | | Significant Split/Dividend | 12:00 am |
| 2026-06-04 | | Information meeting | 05:30 pm |
| 2026-06-04 | | Présentation aux Actionnaires / Analystes | 05:00 pm |
| 2026-06-04 | | Annual General Meeting | 05:00 pm |
| 2026-06-04 | | Annual General Meeting | 02:00 am |
| 2026-06-04 | | Présentation aux Actionnaires / Analystes | 01:00 pm |
| 2026-06-04 | | Annual General Meeting | 09:30 pm |
| 2026-06-04 | | Annual General Meeting | 02:30 am |
| 2026-06-04 | | Présentation aux Actionnaires / Analystes | 09:00 am |
| 2026-06-04 | | Annual General Meeting | 09:00 am |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NRXP Stock
- Calendar NRx Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
